Skip to Main Content

Board of Directors

AUGS members are represented by a 13-member Board of Directors who is responsible for setting the overall strategic direction of the society. The Board is comprised of five officers and eight Directors-at-Large. The officers of the Society include a President, President-Elect, Vice President, Immediate Past President and a Treasurer.

Terms expire at the conclusion of the annual scientific meeting for the year indicated.

AUGS members can send communications to the Board of Directors using the board@augs.org email address. 

 

Officers

 

Cundiff_[1]2018
 
President
Geoffrey W. Cundiff, MD, FACOG, FACS, FRCSC
University of British Columbia
Vancouver, BC Canada
Term Expires: 2019

Corporate Disclosures: None

 

Shawn_Menefee
 
President Elect
Shawn A. Menefee, MD
Kaiser Permanente, San Diego
San Diego, CA
Term Expires: 2019

Corporate Disclosures: Author Royalties - UptoDate

 

 

Holly-E-Richter
 
Vice President
Holly Richter, PhD, MD
University of Alabama at Birmingham
Birmingham, AL
Term Expires: 2019

Corporate Disclosures: Research Grant - Pelvalon; Consultant/Advisory Board - Pelvalon, Renovia, BlueWind Medical; Author Royalties - BlueWind Medical, UptoDate

 

 

 
Flynn
 
Treasurer
Michael K. Flynn, MD, MS
University of Massachusetts 
Worcester, MA
Term Expires: 2021

Corporate Disclosures: None

 

 

Rardin_Charles_2018
 
Immediate Past President
Charles R. Rardin, MD, FACOG, FACS
Alpert Medical School of Brown University
Providence, RI
Term Expires: 2019

Corporate Disclosures: Research Grant - Solace Therapeutics, Foundation for Female Health Awareness; Speaker's Bureau - Symposia Medicus
 

 

 

Directors-at-Large

 
 
Clemons
 
Jeffrey L. Clemons, MD
MultiCare Health System
Tacoma, WA
Term Expires: 2019

Corporate Disclosures: Cosultant/Advisory Board - Ethicon; Author Royalties - UptoDate

 

 

Ferzandi
 
Tanaz R. Ferzandi, MD
Tufts Medical Center
Boston, MA
Term Expires: 2021

Corporate Disclosures: Consultant/Advisory Board - Hologic, Inc. 

 

 

Quiroz
 
Lieschen H. Quiroz, MD
Oklahoma University Health Sciences Center
Oklahoma City, OK
Term Expires: 2021

Corporate Disclosures: Research Grants - Pelvalon, Cook

 

 

Sokol
 
Eric R. Sokol, MD
Stanford University School of Medicine
Stanford, CA
Term Expires: 2020

Corporate Disclosures: Research Grants - ACell, Coloplast, Cook, Foundation for Female Health Awareness; Stock Holdings - Pelvalon

 

TrowbridgeE
 
Elisa R. Trowbridge
University of Virginia
Charlottesville, VA
Term Expires: 2020

Corporate Disclosures: None

 

 

Wu
 
Jennifer M. Wu, MD, MPH
UNC-Chapel Hill
Chapel Hill, NC
Term Expires: 2019

Corporate Disclosures: Personal relationship with employee - United Therapeutics; Research Grants - Pelvalon, Boston Scientific

 

 

 
Noblett
 
PFD Research Foundation Chair
Karen L. Noblett, MD
Axonics Medical Technologies
Irvine, CA
Term Expires: 2019

Corporate Disclosures: Research Grants - Boston Scientific; Employment - Axonics
 

 

 

Tarnay
 
PFD Research Foundation Vice Chair
Christopher M. Tarnay, MD
UCLA School of Medicine
Los Angeles, CA
Term Expires: 2019

Corporate Disclosures: None
 

 

 

Ex-Officio Members

 
Zinnertphoto6.2017
 
AUGS Executive Director
Michelle Zinnert, CAE
American Urogynecologic Society
Silver Spring, MD

 

 

Kilpatrick
 
ACOG Representative
Charles C. Kilpatrick, MD
Baylor College of Medicine
Houston, TX
Term Expires: 2019

Corporate Disclosures: Author Royalties - UptoDate, McGraw Hill

 

 

Corton
 
ABOG Representative

Marlene Corton, MD, MS
UT Southwestern Medical Center
Dallas, TX
Term Expires: 2021


 

 

 

Close